{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:19:38Z","timestamp":1737436778015,"version":"3.33.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.ejphar.2007.08.024","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T11:18:35Z","timestamp":1188299915000},"page":"83-90","source":"Crossref","is-referenced-by-count":14,"title":["Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration"],"prefix":"10.1016","volume":"576","author":[{"given":"Virgili","family":"P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Sosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Barbanoj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Rodr\u00edguez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.08.024_bib1","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.neuroscience.2005.01.038","article-title":"Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity","volume":"132","author":"Alttoa","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.08.024_bib2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-005-0402-5","article-title":"Influence of noradrenaline denervation on MPTP-induced deficits in mice","volume":"113","author":"Archer","year":"2006","journal-title":"J.Neural Transm."},{"key":"10.1016\/j.ejphar.2007.08.024_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/35086062","article-title":"Pathophysiology of levodopa-induced dyskinesia: potential for new therapies","volume":"2","author":"Bezard","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2007.08.024_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/syn.10112","article-title":"Adenosine A2A antagonism reverses Levodopa-induced motor alterations in hemiparkinsonian rats","volume":"46","author":"Bov\u00e9","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2007.08.024_bib5","doi-asserted-by":"crossref","first-page":"46741","DOI":"10.1074\/jbc.M306451200","article-title":"Adenosine A2A\u2013dopamine D2 receptor\u2013receptor heterodimerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer","volume":"278","author":"Canals","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.08.024_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00911-X","article-title":"Scopolamine prevents tolerance to the effects of caffeine on rotational behavior in 6-hydroxydopamine-denervated rats","volume":"366","author":"Casas","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(00)00215-6","article-title":"Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats","volume":"396","author":"Casas","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1073\/pnas.68.3.662","article-title":"Effects of l-DOPA on norepinephrine metabolism in the brain","volume":"68","author":"Chalmers","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2007.08.024_bib9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0022-3565(24)38022-X","article-title":"Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway","volume":"288","author":"Chopin","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.08.024_bib10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM196702162760703","article-title":"Aromatic aminoacids and modification of parkinsonism","volume":"276","author":"Cotzias","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2007.08.024_bib11","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.bjp.0703170","article-title":"The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors","volume":"129","author":"El Yacoubi","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(96)00944-2","article-title":"Adenosine A2A receptor antagonism potentiates l-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats","volume":"321","author":"Fenu","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(96)12577-5","article-title":"Adenosine A1 receptor\u2013dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites","volume":"208","author":"Ferre","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2007.08.024_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine\u2013dopamine receptor\u2013receptor interactions as an integrative mechanism in the basal ganglia","volume":"20","author":"Ferre","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2007.08.024_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(95)00313-A","article-title":"Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice","volume":"283","author":"Fornai","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/neur.1996.0032","article-title":"Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents","volume":"5","author":"Fornai","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.ejphar.2007.08.024_bib17","first-page":"193","article-title":"Noradrenaline loss selectivity exacerbates nigrostriatal toxicity in different species of rodents","volume":"12","author":"Fornai","year":"1997","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1749-6632.1998.tb08231.x","article-title":"Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion","volume":"844","author":"Fornai","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.08.024_bib19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1471-4159.1999.0720777.x","article-title":"Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses","volume":"72","author":"Fornai","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.08.024_bib20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/mds.1148","article-title":"Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan","volume":"16","author":"Fox","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2007.08.024_bib21","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1523\/JNEUROSCI.22-03-01054.2002","article-title":"Persistent behavioral sensitization to chronic l-DOPA requires A2A adenosine receptors","volume":"22","author":"Fredduzzi","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.08.024_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0306-4522(89)90364-3","article-title":"Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals","volume":"30","author":"Fritschy","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.08.024_bib23","first-page":"48","article-title":"Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists","volume":"52","author":"Fuxe","year":"1974","journal-title":"Med. Biol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib69","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0165-0173(97)00049-0","article-title":"Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A\/dopamine D2 and adenosine A1\/dopamine D1 receptor interactions in the basal ganglia","volume":"26","author":"Fuxe","year":"1998","journal-title":"Brain. Res. Brain. Res. Rev."},{"key":"10.1016\/j.ejphar.2007.08.024_bib24","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/01.WNL.0000095206.44418.5C","article-title":"Receptor heteromerization in adenosine A(2A) receptor signalling: relevance for striatal function and \u00b4Parkinson's disease","volume":"61","author":"Fuxe","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2007.08.024_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.brainres.2003.11.028","article-title":"Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on l-DOPA biotransformation in rat striatum","volume":"998","author":"Golembiowska","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.08.024_bib26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neuropharm.2004.04.018","article-title":"Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats","volume":"47","author":"Golembiowska","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2007.08.024_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002109900167","article-title":"Noradrenoceptor antagonism with idazoxan improves l-DOPA-induced dyskinesias in MPTP monkeys","volume":"361","author":"Grondin","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00210-003-0827-z","article-title":"The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats","volume":"368","author":"Haapalinna","year":"2003","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1034\/j.1600-0773.2000.d01-35.x","article-title":"Lesioning of locus coeruleus projections by DSP-4 neurotoxin treatment: effect on amphetamine-induced hyperlocomotion and dopamine D2 receptor binding in rats","volume":"86","author":"Harro","year":"2000","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0006-8993(03)02677-5","article-title":"Effect of denervation of the locus coeruleus projections by DSP-4 treatment on [3H]-raclopride binding to dopamine D(2) receptors and D(2) receptor-G protein interaction in the rat striatum","volume":"976","author":"Harro","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.08.024_bib31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","article-title":"Characterization of enhanced behavioral responses to l-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"151","author":"Henry","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib32","doi-asserted-by":"crossref","first-page":"18091","DOI":"10.1074\/jbc.M107731200","article-title":"Coaggregation cointernalization and codesensitization of adenosine A2A receptors and dopamine D2 receptors","volume":"277","author":"Hillion","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.08.024_bib34","first-page":"19","article-title":"Biochemical pathophysiology of Parkinson's disease","volume":"45","author":"Hornykiewicz","year":"1987","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-2999(81)90272-7","article-title":"DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)a useful denervation tool for central and peripheral noradrenaline neurons","volume":"72","author":"Jonsson","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/exnr.2000.7350","article-title":"Combined use of the adenosine A(2A) antagonist KW-6002 with l-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys","volume":"162","author":"Kanda","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(00)00745-7","article-title":"Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats","volume":"408","author":"Koga","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib38","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/jpet.104.076554","article-title":"Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors","volume":"312","author":"Lane","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.08.024_bib71","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nature00817","article-title":"Involvement of DARP-32 phosphorylation in the stimulant action of caffeine","volume":"418","author":"Lindskog","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.08.024_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(03)00295-7","article-title":"Rapid induction of serotonergic hyperinnervation in the adult rat striatum with extensive dopaminergic denervation","volume":"343","author":"Maeda","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2007.08.024_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2005.04.019","article-title":"Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA","volume":"1046","author":"Maeda","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.08.024_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0014-2999(93)90489-5","article-title":"Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice","volume":"236","author":"Marien","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(76)91416-1","article-title":"\u201cOn\u2013off\u201d effects in patients with Parkinson's disease on chronic levodopa therapy","volume":"1","author":"Marsden","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2007.08.024_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(91)90345-O","article-title":"Effects of locus coeruleus lesions on parkinsonian signs striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1236-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease","volume":"41","author":"Mavridis","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.08.024_bib44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0006-8993(91)90624-5","article-title":"Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists","volume":"562","author":"Mavridis","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.08.024_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0014-4886(03)00316-9","article-title":"Adenosine A2A antagonists: potential preventive and palliative treatment for Parkinson's disease","volume":"184","author":"Morelli","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0304-3940(91)90941-L","article-title":"Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1236-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by l-DOPA","volume":"123","author":"Nishi","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2007.08.024_bib48","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.410390504","article-title":"The response to levodopa in Parkinson's disease: imposing pharmacological law and order","volume":"39","author":"Nutt","year":"1996","journal-title":"Ann. Neurol."},{"issue":"10 Suppl","key":"10.1016\/j.ejphar.2007.08.024_bib49","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","article-title":"Levodopa motor complications in Parkinson's disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2007.08.024_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1460-9568.1999.00415.x","article-title":"Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin","volume":"11","author":"Okada","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.08.024_bib51","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1471-4159.1995.64031118.x","article-title":"Effect of noradrenergic lesions on subtypes of alpha 2-adrenoceptors in rat brain","volume":"64","author":"Ordway","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.08.024_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-8993(94)90796-X","article-title":"Motor fluctuations in levodopa-treated parkinsonian rats: relation to lesion extent and treatment duration","volume":"662","author":"Papa","year":"1994","journal-title":"Brain Res."},{"year":"1982","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","key":"10.1016\/j.ejphar.2007.08.024_bib53"},{"key":"10.1016\/j.ejphar.2007.08.024_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0197-0186(02)00091-8","article-title":"PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] a new MAO-B inhibitor attenuates MPTP-induced depletion of striatal dopamine levels in C57\/BL6 mice","volume":"42","author":"Perez","year":"2003","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2007.08.024_bib55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K","article-title":"Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats","volume":"39","author":"Pinna","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2007.08.024_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(02)01818-6","article-title":"Modification of adenosine extracellular levels and adenosine A2A receptor mRNA by dopamine denervation","volume":"446","author":"Pinna","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s007020070083","article-title":"The novel type b MAO inhibitor PF9601N enhances the duration of l-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats","volume":"107","author":"Prats","year":"2000","journal-title":"J Neural Transm."},{"key":"10.1016\/j.ejphar.2007.08.024_bib57","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mds.1143","article-title":"Idazoxan an alpha-2 antagonist and l-DOPA-induced dyskinesias in patients with Parkinson's disease","volume":"16","author":"Rascol","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2007.08.024_bib58","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1476-5381.1976.tb08619.x","article-title":"Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine.HCl on noradrenergic neurones in the rat brain and heart","volume":"58","author":"Ross","year":"1976","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.08.024_bib59","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/mds.10464","article-title":"Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"18","author":"Savola","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2007.08.024_bib60","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1046\/j.1460-9568.2003.02684.x","article-title":"Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats","volume":"17","author":"Srinivasan","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.08.024_bib61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbr.2004.03.002","article-title":"Treatment with alpha2-adrenoceptor antagonist 2-methoxy idazoxan protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence","volume":"154","author":"Srinivasan","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2007.08.024_bib62","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00702-004-0259-z","article-title":"Serotonergic influence on the potentiation of d-amphetamine and apomorphine-induced rotational behavior by the alpha(2)-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats","volume":"112","author":"Srinivasan","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2007.08.024_bib72","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0306-4522(97)00046-8","article-title":"Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA por NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens","volume":"79","author":"Svenningsson","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.08.024_bib63","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0306-4522(98)00403-5","article-title":"Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons","volume":"89","author":"Svenningsson","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.08.024_bib64","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001756-199902250-00034","article-title":"Role of serotonergic neurons in l-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats","volume":"10","author":"Tanaka","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2007.08.024_bib73","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.parkreldis.2004.02.015","article-title":"Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease","volume":"10","author":"Tanganelli","year":"2004","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1016\/j.ejphar.2007.08.024_bib65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1016\/j.ejphar.2007.08.024_bib66","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0014-5793(98)01588-9","article-title":"Dopamine D2 receptor dimers in human and rat brain","volume":"441","author":"Zawarynski","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2007.08.024_bib67","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0022-3565(24)38271-0","article-title":"alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine","volume":"289","author":"Zhang","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907009363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907009363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:00:38Z","timestamp":1737396038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907009363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":70,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0014299907009363"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.08.024","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}